11-011
Showing 1 - 25 of 8,208
NSCLC Trial in China (JAB 21822)
Recruiting
- Non-small Cell Lung Cancer
- JAB 21822
-
Beijing, Beijing, China
- +20 more
Sep 26, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Rheumatoid Arthritis Trial in Worldwide (TL011, anti CD20, for the treatment of rheumatoid arthritis, MabThera infusions)
Completed
- Rheumatoid Arthritis
- TL011, anti CD20, for the treatment of rheumatoid arthritis
- MabThera infusions
-
Plzen, Czechia
- +17 more
Sep 7, 2021
Chronic Hand Eczema Trial in Canada, Spain, United Kingdom (Delgocitinib, Cream vehicle)
Recruiting
- Chronic Hand Eczema
- Delgocitinib
- Cream vehicle
-
Darlinghurst, Australia
- +25 more
Dec 12, 2022
Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- CB-011
-
New York, New York
- +3 more
Feb 15, 2023
Without Magnetic Resonance Image in Thoracolumbar Fractures
Completed
- Spinal Deformity
- +3 more
- Retrospective radiological evaluation
-
Hangzhou, China
- +4 more
Aug 11, 2020
Chronic Hand Eczema Trial in Worldwide (Delgocitinib cream, Cream vehicle)
Completed
- Chronic Hand Eczema
- Delgocitinib cream
- Cream vehicle
-
Calgary, Alberta, Canada
- +53 more
Nov 1, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Nemtabrutinib
- +2 more
- (no location specified)
Nov 22, 2023
Study on Patterns of Care in Mild Asthmatic Patients
Completed
- Asthma
-
Berlin, Germany
- +58 more
Sep 26, 2022
End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Trial in Edgewater, Tampa (MK-2060, Placebo)
Recruiting
- End-Stage Renal Disease
- +2 more
- MK-2060
- Placebo
-
Edgewater, Florida
- +1 more
Jan 30, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
Relapsing Remitting Multiple Sclerosis Trial (monomethyl fumarate 190 mg, dimethyl fumarate 240 mg)
Completed
- Relapsing Remitting Multiple Sclerosis
- monomethyl fumarate 190 mg
- dimethyl fumarate 240 mg
- (no location specified)
Dec 5, 2022